| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.97B | 51.05B | 50.24B | 47.43B | 45.32B | 42.59B |
| Gross Profit | 13.06B | 13.55B | 12.57B | 10.60B | 11.16B | 11.46B |
| EBITDA | 2.86B | 3.44B | 3.41B | 1.58B | 2.06B | 2.10B |
| Net Income | 1.02B | 1.55B | 1.51B | 267.97M | 635.03M | 600.32M |
Balance Sheet | ||||||
| Total Assets | 26.63B | 26.90B | 27.64B | 25.10B | 24.44B | 23.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.30B | 2.28B | 2.18B | 2.11B | 1.83B | 1.84B |
| Total Debt | 3.85B | 3.38B | 5.57B | 5.63B | 5.56B | 5.29B |
| Total Liabilities | 9.61B | 9.51B | 11.80B | 10.95B | 10.57B | 10.52B |
| Stockholders Equity | 17.01B | 17.39B | 15.84B | 14.16B | 13.87B | 13.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.50B | 153.46M | 260.00M | -254.55M | 1.52B |
| Operating Cash Flow | 0.00 | 3.46B | 1.38B | 959.52M | 442.38M | 2.00B |
| Investing Cash Flow | 0.00 | -763.49M | -1.10B | -533.84M | -438.25M | -238.96M |
| Financing Cash Flow | 0.00 | -2.58B | -247.56M | -179.58M | -78.33M | -1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥11.15B | 20.91 | ― | 2.39% | -0.37% | -54.58% | |
68 Neutral | ¥22.12B | 21.22 | ― | 1.74% | 7.66% | 2.64% | |
68 Neutral | ¥4.28B | 15.73 | ― | 1.55% | -1.00% | 31.15% | |
66 Neutral | ¥6.19B | 14.86 | ― | 1.22% | 1.52% | 28.70% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥13.86B | 34.48 | ― | 1.61% | 0.48% | -34.95% | |
49 Neutral | ¥11.72B | 76.99 | ― | 0.84% | 4.28% | ― |